Asiri Hospitals Ltd.

ASIR.N0000

Healthcare · Hospital/Nursing Management

Rs 33.00
-1.49%
as of Aug 3, 2026
Price history
-4.62%
P/E
7.7
P/B
1.53
EPS
Rs 4.28
Div Yield
0.00%
Market Cap
Rs 37.5B
Beta
2.00
ROE
8.4%
Op Margin
22.1%

Annual fundamentals

YearRevenueNet profitEPS
2025Rs 31.0BRs 1.8B1.44
2024Rs 28.6BRs 3.1B2.54
2023Rs 24.8BRs 1.7B1.29
2022Rs 22.3BRs 3.8B3.08
2021Rs 15.8BRs 1.7B1.35
2020Rs 15.5BRs 918.2M0.71
2019Rs 13.5BRs 1.8B1.48

Recent dividends

  • 2025 · first interimRs 1.50
  • 2022 · second interimRs 1.20
  • 2022 · first interimRs 1.30
  • 2021 · second interimRs 0.80
  • 2021 · first interimRs 0.80
  • 2016Rs 0.45
  • 2015Rs 1.94
  • 2015Rs 0.50

About Asiri Hospitals Ltd.

Asiri Hospital Holdings PLC (Asiri Health) is a private healthcare group operating in Sri Lanka and is the owner and operator of the Asiri Hospital network. The Group operates seven internationally accredited hospitals and runs the country’s largest private medical diagnostics network, serving patients across the island. The Group’s hospital operations provide inpatient, outpatient and specialised clinical services including cardiology, oncology, renal care, advanced surgery, geriatric medicine and reproductive medicine, with the Asiri Fertility Centre noted as Sri Lanka’s only facility fully compliant with international Assisted Reproductive Technology (ART) guidelines. Group hospitals hold international accreditations such as Joint Commission International (JCI) and ACHSI. Asiri Laboratories, the Group’s diagnostic arm, operates an extensive nationwide network of collection centres, satellite and hospital-based laboratories and maintains international ISO accreditations for laboratory quality and competence. The Group has also expanded into healthcare education through the Asiri Academy of Health Sciences, which provides training and professional development for healthcare personnel in Sri Lanka and the region.

AI analysis

neutral

Quarterly profit rose 33% year-on-year, yet Asiri trades at 7.7x P/E; a March CSE enforcement action keeps a compliance overhang.

Read the full report (Aug 3, 2026) →

News sentiment

Describes news flow, not a forecast
Last 30 days
Not enough news to read

No scored news in the last 30 days.

24 months positive negative 3-month net
Sep 24: 3 articles, net +0.33Jul 25: 2 articles, net +0.50Sep 25: 2 articles, net -0.50Mar 26: 3 articles, net -1.00Apr 24Aug 24Dec 24Apr 25Aug 25Dec 25
Recent news
View all news →

Healthcare sector: what is happening

Last 30 days to Aug 4, 2026

SLPMA dominated sector news, urging a long-term government buyback to back local pharma manufacturing, quicker raw-material import approvals and stable incentives, plus a national push to make pharmaceuticals an export engine through a task force and faster regulation. Cross-border activity featured a 31-member Indian delegation on 8-10 July for B2B sessions including pharma. Colombo Port City moved to seek operators for an international hospital. Cybersecurity risks to hospitals gained attention.

Auto-generated from 8 sector news articles over 30 days. Not investment advice. 2 more stories on the sentiment page.